Epistemic Barriers to Buprenorphine Access for Adolescents With Opioid Use Disorder.  Babul A, Ashraf S, Elmes R, Mahdavi P.  Cureus. 2026 May 14;18(5):e108824. doi: 10.7759/cureus.108824. PMID: 42148195; PMCID: PMC13173305. https://pmc…

A geospatial analysis of access to syringe services programs in the United States, 2023.  Humphrey JL, Patel SV, Strack CN, Lindstrom M, Saunders ME, LaKosky P, Kral AH, Lambdin BH.  Drug Alcohol Depend. 2026 Apr 20;284:113168. doi: 10.1…

Willingness to use a mobile syringe service program among people who inject drugs in rural Appalachia.  Elswick A, Fallin-Bennett A, Jahangir T, Westneat S, Young AM.  Harm Reduct J. 2026 Apr 22. doi: 10.1186/s12954-026-01461-7. Epub ahe…

Naloxone and Clinical Outcomes in Suspected Opioid-Associated Out-of-Hospital Cardiac Arrests.  Wang RC, Toy J, Montoy JCC, et al.  JAMA Netw Open. 2026;9(5):e2615539. doi:10.1001/jamanetworkopen.2026.15539 https://jamanetwork.com/journ…

Naloxone for Out-of-Hospital Cardiac Arrest Due to Opioid Toxicity.  Grunau B, Rea T.  JAMA Netw Open. 2026;9(5):e2615547. doi:10.1001/jamanetworkopen.2026.15547 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2849636

‘If you've ever experienced it, you'd feel differently’: Exploring willingness and skepticism toward using higher dose naloxone products among people who use drugs in Maryland, United States.  Sisson LN, Rousch RS, Hill LG, Zagorski CM, Triece…